Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

Autor: Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina. Electronic address: michael.grunwald@atriumhealth.org., Sha W; Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC, 28204., He J; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Sanikommu S; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Gerber JM; Department of Medicine, Division of Hematology & Medical Oncology, New York University Grossman School of Medicine, New York, New York., Ai J; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Knight TG; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Fasan O; GLPG US, Princeton, New Jersey., Boseman V; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Kaizen W; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Chojecki A; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Ragon BK; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Symanowski J; Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC, 28204., Avalos B; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Copelan E; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Ghosh N; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina; Section On Hematology and Medical Oncology, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Dec; Vol. 30 (12), pp. 1211.e1-1211.e11. Date of Electronic Publication: 2024 Sep 26.

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.

Autor: Morschhauser F; Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. franck.morschhauser@chu-lille.fr., Dahiya S; Stanford University School of Medicine, Stanford, CA, USA.; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Martin Garcia-Sancho A; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain., Reguera Ortega JL; Hospital Virgen del Rocío, Instituto de Biomedicina de la Universidad de Sevilla, Seville, Spain., Kuruvilla J; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Jäger U; Medical University of Vienna, Vienna, Austria., Cartron G; Montpellier University Hospital Center, UMR CNRS 5535, Montpellier, France., Izutsu K; National Cancer Center Hospital, Tokyo, Japan., Dreyling M; LMU University Hospital, München, Germany., Kahl B; Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Ghesquieres H; Hôpital Lyon Sud, Lyon, France., Ardeshna K; University College London Hospitals Biomedical Research Centre, London, UK., Goto H; Hokkaido University Hospital, Sapporo, Japan., Barbui AM; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Abramson JS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Borchmann P; Universität zu Köln, Köln, Germany., Fleury I; Hôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada., Mielke S; Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden., Skarbnik A; Novant Health Cancer Institute, Charlotte, NC, USA., de Vos S; UCLA Santa Monica Medical Centre, Santa Monica, CA, USA., Kamdar M; University of Colorado Cancer Center, Aurora, CO, USA., Karmali R; Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Viardot A; Department of Internal Medicine III, University Hospital, Ulm, Germany., Farazi T; Bristol Myers Squibb, Brisbane, CA, USA., Fasan O; Bristol Myers Squibb, Princeton, NJ, USA., Lymp J; Bristol Myers Squibb, Seattle, WA, USA., Vedal M; Bristol Myers Squibb, Seattle, WA, USA., Nishii R; Bristol Myers Squibb, Princeton, NJ, USA., Avilion A; Bristol Myers Squibb, Seattle, WA, USA., Papuga J; Bristol Myers Squibb, Boudry, Switzerland., Kumar J; Bristol Myers Squibb, Princeton, NJ, USA., Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2199-2207. Date of Electronic Publication: 2024 Jun 03.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P367 Understanding psychosocial parameters affecting level of physical activity in adults with cystic fibrosis

Autor: Fasan, O., Masson, A., Mandigout, S., Thomas, F., Languepin, J., Borel, B.

Publikováno v: In Journal of Cystic Fibrosis June 2020 19 Supplement 2:S158-S159

A New Approach of Detecting ALK Fusion Oncogenes by RNA Sequencing Exon Coverage Analysis.

Autor: Zakharova, Galina¹ (AUTHOR) galina.s.zakharova@gmail.com, Suntsova, Maria^1,2 (AUTHOR) suntsova_m_v@staff.sechenov.ru, Rabushko, Elizaveta¹ (AUTHOR) elnrabush@gmail.com, Mohammad, Tharaa² (AUTHOR), Drobyshev, Alexey¹ (AUTHOR) drobyshev_a_l@staff.sechenov.ru, Seryakov, Alexander³ (AUTHOR) alseryakov@yandex.ru, Poddubskaya, Elena^1,4 (AUTHOR) podd-elena@ya.ru, Moisseev, Alexey^1,5 (AUTHOR) moiseev_a_a@staff.sechenov.ru, Smirnova, Anastasia^1,5 (AUTHOR) liliumanstist@gmail.com, Sorokin, Maxim^1,5 (AUTHOR) sorokin@oncobox.com, Tkachev, Victor⁵ (AUTHOR), Simonov, Alexander¹ (AUTHOR) simonov@oncobox.com, Guguchkin, Egor⁶ (AUTHOR) guguchkin@ispras.ru, Karpulevich, Evgeny⁶ (AUTHOR) karpulevich@ispras.ru, Buzdin, Anton^1,7,8 (AUTHOR) buzdin_a_a@staff.sechenov.ru

Publikováno v: Cancers. Nov2024, Vol. 16 Issue 22, p3851. 21p.